SCHEMBL4037362

SCHEMBL4037362

CC(C)CC(O)(Cc1cc2cccc(F)c2[nH]1)C(F)(F)F

nearest known ligand 0.57

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 19/20 0.57
NR3C2 P08235 14/20 0.57
PGR P06401 13/20 0.57
DAO P14920 1/20 0.39
DDO Q99489 1/20 0.39
CYP3A4 P08684 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3653908 0.82 NR3C1 (0.55) NR3C1NR3C2PGR
SCHEMBL3684073 0.81 NR3C1 (0.42) NR3C1NR3C2PGRCYP3A4
SCHEMBL1634355 0.79 NR3C1 (0.67) NR3C1NR3C2PGRCYP3A4
SCHEMBL1635102 0.78 NR3C1 (0.71) NR3C1NR3C2PGRCYP3A4
SCHEMBL1635345 0.77 NR3C1 (0.70) NR3C1NR3C2PGRCYP3A4
SCHEMBL1634433 0.75 NR3C1 (0.77) NR3C1NR3C2PGRCYP3A4
SCHEMBL1633555 0.75 NR3C1 (0.74) NR3C1NR3C2PGRCYP3A4
SCHEMBL1635848 0.75 NR3C1 (0.77) NR3C1NR3C2PGRCYP3A4
SCHEMBL4037364 0.75 NR3C1 (0.42) NR3C1NR3C2PGRDAODDO
SCHEMBL14340577 0.74 NR3C1 (0.74) NR3C1NR3C2PGRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061444-A2 COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, AMELIORATING, OR PREVENTING ALLERGY Bausch & Lomb Incorporated (US) 2009-05-27 EP disclosed
EP-2051710-A2 COMPOSITIONS AND METHODS FOR TREATING, REDUCING, AMELIORATING, OR ALLEVIATING POSTERIOR-SEGMENT OPHTHALMIC DISEASES Bausch & Lomb Incorporated (US) 2009-04-29 EP disclosed
WO-2008033655-A2 COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, AMELIORATING, OR PREVENTING ALLERGY BAUSCH & LOMB INCORPORATED (US) 2008-03-20 WO disclosed
WO-2008021729-A2 COMPOSITIONS AND METHODS FOR TREATING, REDUCING, AMELIORATING, OR ALLEVIATING POSTERIOR-SEGMENT OPHTHALMIC DISEASES BAUSCH & LOMB INCORPORATED (US) 2008-02-21 WO disclosed